Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000851460) titled 'ElectroPulseTM Pulsed Field Ablation System to Treat Atrial Fibrillation' on Aug. 6.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: CathRx Ltd
Condition:
Persistent Atrial Fibrillation (AF)
Paroxysmal Atrial Fibrillation (AF)
Persistent Atrial Fibrillation (AF)
Paroxysmal Atrial Fibrillation (AF)
Cardiovascular - Other cardiovascular diseases
Intervention:
The ElectroPulse Pulsed Field Ablation (PFA) System is a medical device which is used to perfor...